CD4 and pneumocystosis: TMP/SMX prophylaxis for Pneumocystis jirovecii pneumonia (pcp) is used in many settings for HIV-infected patients with a low CD4 count, and it might also be effective against the C. belli parasite (Anglaret et al., 1999).